Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
2.180
-0.100 (-4.39%)
Nov 20, 2024, 4:00 PM EST - Market closed

Sunshine Biopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
32.9624.094.350.230.070.02
Upgrade
Revenue Growth (YoY)
61.94%454.42%1802.41%219.88%238.10%-
Upgrade
Cost of Revenue
22.8115.752.650.120.030.01
Upgrade
Gross Profit
10.148.341.70.110.050.01
Upgrade
Selling, General & Admin
12.9510.839.481.870.610.62
Upgrade
Research & Development
1.61.860.810.6700.02
Upgrade
Other Operating Expenses
0.350.290.06---
Upgrade
Operating Expenses
15.1113.1210.372.550.620.65
Upgrade
Operating Income
-4.96-4.79-8.67-2.44-0.58-0.64
Upgrade
Interest Expense
-0.03-0.14-0.04-0.33-0.17-0.12
Upgrade
Interest & Investment Income
0.580.810.52---
Upgrade
Currency Exchange Gain (Loss)
0.3-0-000-0.02
Upgrade
Other Non Operating Income (Expenses)
----0-
Upgrade
EBT Excluding Unusual Items
-4.11-4.11-8.2-2.77-0.74-0.77
Upgrade
Impairment of Goodwill
---18.33---
Upgrade
Other Unusual Items
--0.01-9.67-2.05-0.31
Upgrade
Pretax Income
-4.11-4.11-26.51-12.44-2.78-1.08
Upgrade
Income Tax Expense
0.110.40.23---
Upgrade
Earnings From Continuing Operations
-4.23-4.51-26.74-12.44-2.78-1.08
Upgrade
Earnings From Discontinued Operations
------0.58
Upgrade
Net Income
-4.23-4.51-26.74-12.44-2.78-1.66
Upgrade
Net Income to Common
-4.23-4.51-26.74-12.44-2.78-1.66
Upgrade
Shares Outstanding (Basic)
00----
Upgrade
Shares Outstanding (Diluted)
00----
Upgrade
EPS (Basic)
-25.31-370.38----
Upgrade
EPS (Diluted)
-26.01-380.00----
Upgrade
Free Cash Flow
-12.99-8.86-5.44-1.83-0.66-0.5
Upgrade
Free Cash Flow Per Share
-77.78-728.04----
Upgrade
Gross Margin
30.78%34.61%39.04%48.42%63.80%47.68%
Upgrade
Operating Margin
-15.05%-19.86%-199.60%-1068.24%-807.83%-3037.91%
Upgrade
Profit Margin
-12.82%-18.70%-615.44%-5444.41%-3898.74%-7860.85%
Upgrade
Free Cash Flow Margin
-39.40%-36.76%-125.24%-800.75%-922.13%-2351.49%
Upgrade
EBITDA
-4.76-4.64-8.65-2.43-0.56-0.63
Upgrade
EBITDA Margin
-14.45%-19.24%-199.03%---
Upgrade
D&A For EBITDA
0.20.150.030.010.010.01
Upgrade
EBIT
-4.96-4.79-8.67-2.44-0.58-0.64
Upgrade
EBIT Margin
-15.05%-19.86%-199.60%---
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.